Amniotic fluid (AF) culture medium has been recognized for its significant advantages in various applications, particularly in stem cell biology and regenerative medicine. AF contains a diverse range of cells, including fetal skin, gastrointestinal, respiratory, and urinary tract cells, as well as amniotic membrane cells. These cells are obtained through amniocentesis, a widely accessible and common procedure for diagnostic testing.

One of the primary advantages of using AF culture medium is its ability to support the growth and differentiation of multipotent fetal-derived cells, which have the potential to differentiate into ectodermal, mesodermal, and endodermal lineages. This differentiation potential is crucial for the development of cell-based therapies and regenerative medicine, as it allows for the generation of various cell types that can be used to repair and replace damaged tissues.

AF culture medium also provides a rich source of growth factors, hormones, and other biologically active molecules that support cell growth and differentiation. These factors contribute to the high proliferation rate and substantial differentiation potential of AF-derived cells, making them a promising resource for various applications.

In addition to its role in cell culture, AF culture medium has been used in diagnostic testing for prenatal genetic analysis, including standard karyotyping and other genetic and molecular tests. AF samples are routinely used to evaluate fetal lung maturity, metabolic diseases, fetal infections, and intrauterine infections. The use of chromosomal microarray (CMA) has further enhanced the ability to detect genetic abnormalities in AF samples, providing valuable information about the fetus and its development.